GB1429534A - Method for preparation of insoluble biologically active materials - Google Patents

Method for preparation of insoluble biologically active materials

Info

Publication number
GB1429534A
GB1429534A GB1399673A GB1399673A GB1429534A GB 1429534 A GB1429534 A GB 1429534A GB 1399673 A GB1399673 A GB 1399673A GB 1399673 A GB1399673 A GB 1399673A GB 1429534 A GB1429534 A GB 1429534A
Authority
GB
United Kingdom
Prior art keywords
preparation
biologically active
active materials
insoluble biologically
streptomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1399673A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Publication of GB1429534A publication Critical patent/GB1429534A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)

Abstract

1429534 Streptomycin CESKOSLOVENSKA AKADEMIE VED 22 March 1973 [29 March 1972] 13996/73 Heading C2C [Also in Divisions C3 and A5] Streptomycin is insolubilized by treatment with a copolymer of 2-hydroxyethyl methacrylate and ethylene dimethacrylate which has been activated with cyanogen bromide (see Division C3).
GB1399673A 1972-03-29 1973-03-22 Method for preparation of insoluble biologically active materials Expired GB1429534A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS722106A CS167530B1 (en) 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation

Publications (1)

Publication Number Publication Date
GB1429534A true GB1429534A (en) 1976-03-24

Family

ID=5357203

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1399673A Expired GB1429534A (en) 1972-03-29 1973-03-22 Method for preparation of insoluble biologically active materials

Country Status (11)

Country Link
JP (1) JPS5738236B2 (en)
AT (1) AT336180B (en)
BE (1) BE797512A (en)
CA (1) CA999820A (en)
CH (1) CH577524A5 (en)
CS (1) CS167530B1 (en)
DE (1) DE2315508A1 (en)
FR (1) FR2178085B1 (en)
GB (1) GB1429534A (en)
NL (1) NL7304275A (en)
SE (1) SE411905B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103184A2 (en) * 1982-08-12 1984-03-21 Kanegafuchi Chemical Industry Co., Ltd. Activation of biocompatible terpolymers with biologicals whose binding complements are pathological effectors
AU570213B2 (en) * 1982-08-12 1988-03-10 Kanegafuchi Chemical Industry Co. Ltd. Biospecific polymer with biocompatible terpolymer support
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
EP0420598A2 (en) * 1989-09-26 1991-04-03 Academy of Sciences of the Czech Republic Contact lens based on a hydrophilic gel

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2621974A1 (en) * 1976-05-18 1977-11-24 Max Planck Gesellschaft PROCESS FOR PRODUCING A COVALENT BOND WITH BIOLOGICALLY ACTIVE MATERIALS
JPS5836624B2 (en) * 1978-04-05 1983-08-10 旭化成株式会社 Adsorbent for blood processing
US4530963A (en) * 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions
HU186566B (en) * 1982-08-24 1985-08-28 Reanal Finomvegyszergyar Process for immobilisation of combinations consisting nucleofil group
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4685900A (en) * 1983-06-01 1987-08-11 Biospecific Technologies, Inc. Therapeutic device
JPH0644927B2 (en) * 1987-03-14 1994-06-15 日本油脂株式会社 Sustained release active ingredient release agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603393A (en) * 1967-12-27 1971-04-13

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103184A2 (en) * 1982-08-12 1984-03-21 Kanegafuchi Chemical Industry Co., Ltd. Activation of biocompatible terpolymers with biologicals whose binding complements are pathological effectors
EP0103184A3 (en) * 1982-08-12 1985-06-19 Diamond Shamrock Chemicals Company Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
AU570213B2 (en) * 1982-08-12 1988-03-10 Kanegafuchi Chemical Industry Co. Ltd. Biospecific polymer with biocompatible terpolymer support
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
WO1989001335A1 (en) * 1987-08-14 1989-02-23 Kanegafuchi Chemical Industry Co., Ltd. Biospecific polymers
EP0420598A2 (en) * 1989-09-26 1991-04-03 Academy of Sciences of the Czech Republic Contact lens based on a hydrophilic gel
EP0420598A3 (en) * 1989-09-26 1992-04-01 Czechoslovak Academy Of Sciences Contact lens based on a hydrophilic gel

Also Published As

Publication number Publication date
CH577524A5 (en) 1976-07-15
JPS5738236B2 (en) 1982-08-14
AT336180B (en) 1977-04-25
CA999820A (en) 1976-11-16
CS167530B1 (en) 1976-04-29
FR2178085A1 (en) 1973-11-09
JPS4913385A (en) 1974-02-05
DE2315508C2 (en) 1987-07-16
FR2178085B1 (en) 1977-04-29
DE2315508A1 (en) 1973-10-18
NL7304275A (en) 1973-10-02
SE411905B (en) 1980-02-11
ATA278873A (en) 1976-08-15
BE797512A (en) 1973-07-16

Similar Documents

Publication Publication Date Title
ES2011120A6 (en) Dosage form for treating cardiovascular diseases comprising isradipine
GB1429534A (en) Method for preparation of insoluble biologically active materials
JPS4813333B1 (en)
ES462045A1 (en) Absorbent article
GB1435577A (en) Pesticide
ES422768A1 (en) Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
ATE42202T1 (en) THERAPEUTIC PREPARATION WITH AMMONIUM NITRATE AS AN ACTIVE SUBSTANCE.
ZA834119B (en) Optically active derivatives of n-arylated oxazolidine-2-one,the process for preparing same and their application in therapeutics
YU146270A (en) Process for producing a novel biologically active substance pepstatine
GB1483105A (en) Method of rendering catheter hydrophilic
SU633525A1 (en) Ocular implant with prosthesis
BE866365A (en) 3,1-S-ALPHA2-GLYCOPROTEIN RICH IN LEUCINE, ITS PREPARATION PROCESS AND ITS USE
GB1509745A (en) Pharmaceutically active polypeptides
JPS5247883A (en) Preparation of molded product of hydrogel
JPS51127185A (en) A process for polymerizing olefin
ES429522A1 (en) Procedure for preparing an acrylic fiber for improved hydroscopicity. (Machine-translation by Google Translate, not legally binding)
CA943137A (en) Process for racemizing optically active 3,4-dihydroxyphenylalanine and its derivatives
JPS5221336A (en) Cosmetic utilizing spirulina alga
JPS5326312A (en) Preparation of antiphlogistic substance
SE7514774L (en) ACCELERATOR FOR FREE-RADICAL CATALYZED POLYMERIZATION.
ES8200701A1 (en) A process for decreasing the phenylalanine content of protein hydrolysates and meat-aroma concentrates prepared therefrom
FR289M (en) Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.
GB1228362A (en)
ES8207509A1 (en) Transetherification in amides
GEP19991402B (en) Method of treatment of tube sterility of an inflammatory genesis

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee